ENST00000597453.1:n.375delC
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000597453.1(TGFB1):n.375delC variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,614,128 control chromosomes in the GnomAD database, including 213 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 20 hom., cov: 31)
Exomes 𝑓: 0.015 ( 193 hom. )
Consequence
TGFB1
ENST00000597453.1 non_coding_transcript_exon
ENST00000597453.1 non_coding_transcript_exon
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.563
Publications
19 publications found
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
- Camurati-Engelmann diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- inflammatory bowel disease, immunodeficiency, and encephalopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 19-41342037-TG-T is Benign according to our data. Variant chr19-41342037-TG-T is described in ClinVar as Benign. ClinVar VariationId is 197687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.011 (1669/152248) while in subpopulation NFE AF = 0.0175 (1189/68010). AF 95% confidence interval is 0.0167. There are 20 homozygotes in GnomAd4. There are 813 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFB1 | NM_000660.7 | c.713-8delC | splice_region_variant, intron_variant | Intron 4 of 6 | ENST00000221930.6 | NP_000651.3 | ||
| TGFB1 | XM_011527242.3 | c.713-5delC | splice_region_variant, intron_variant | Intron 4 of 6 | XP_011525544.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000221930.6 | c.713-8delC | splice_region_variant, intron_variant | Intron 4 of 6 | 1 | NM_000660.7 | ENSP00000221930.4 |
Frequencies
GnomAD3 genomes AF: 0.0110 AC: 1670AN: 152130Hom.: 20 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1670
AN:
152130
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0128 AC: 3207AN: 251012 AF XY: 0.0132 show subpopulations
GnomAD2 exomes
AF:
AC:
3207
AN:
251012
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0149 AC: 21784AN: 1461880Hom.: 193 Cov.: 33 AF XY: 0.0148 AC XY: 10763AN XY: 727238 show subpopulations
GnomAD4 exome
AF:
AC:
21784
AN:
1461880
Hom.:
Cov.:
33
AF XY:
AC XY:
10763
AN XY:
727238
show subpopulations
African (AFR)
AF:
AC:
80
AN:
33480
American (AMR)
AF:
AC:
266
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
267
AN:
26136
East Asian (EAS)
AF:
AC:
4
AN:
39700
South Asian (SAS)
AF:
AC:
581
AN:
86256
European-Finnish (FIN)
AF:
AC:
790
AN:
53420
Middle Eastern (MID)
AF:
AC:
288
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
18696
AN:
1112002
Other (OTH)
AF:
AC:
812
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1427
2854
4281
5708
7135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0110 AC: 1669AN: 152248Hom.: 20 Cov.: 31 AF XY: 0.0109 AC XY: 813AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
1669
AN:
152248
Hom.:
Cov.:
31
AF XY:
AC XY:
813
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
112
AN:
41546
American (AMR)
AF:
AC:
117
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
33
AN:
3470
East Asian (EAS)
AF:
AC:
4
AN:
5184
South Asian (SAS)
AF:
AC:
23
AN:
4826
European-Finnish (FIN)
AF:
AC:
140
AN:
10616
Middle Eastern (MID)
AF:
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1189
AN:
68010
Other (OTH)
AF:
AC:
32
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
84
168
251
335
419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 18, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 03, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.